Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2007 Feb 16;8(1):E87–E93. doi: 10.1208/pt0801012

Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting

Amol Paharia 1,✉, Awesh K Yadav 1, Gopal Rai 1, Sunil K Jain 2, Shyam S Pancholi 3, Govind P Agrawal 3,✉
PMCID: PMC2750447  PMID: 17408212

Abstract

An objective of the present investigation was to prepare and evaluate Eudragit-coated pectin microspheres for colon targeting of 5-fluorouracil (FU). Pectin microspheres were prepared by emulsion dehydration method using different ratios of FU and pectin (1:3 to 1:6), stirring speeds (500–2000 rpm) and emulsifier concentrations (0.75%–1.5% wt/vol). The yield of preparation and the encapsulation efficiencies were high for all pectin microspheres. Microspheres prepared by using drug:polymer ratio 1:4, stirring speed 1000 rpm, and 1.25% wt/vol concentration of emulsifying agent were selected as an optimized formulation. Eudragit-coating of pectin microspheres was performed by oil-in-oil solvent evaporation method using coat: core ratio (5:1). Pectin microspheres and Eudragit-coated pectin microspheres were evaluated for surface morphology, particle size and size distribution, swellability, percentage drug entrapment, and in vitro drug release in simulated gastrointestinal fluids (SGF). The in vitro drug release study of optimized formulation was also performed in simulated colonic fluid in the presence of 2% rat cecal content. Organ distribution study in albino rats was performed to establish the targeting potential of optimized formulation in the colon. The release profile of FU from Eudragit-coated pectin microspheres was pH dependent. In acidic medium, the release rate was much slower; however, the drug was released quickly at pH 7.4. It is concluded from the present investigation that Eudragit-coated pectin microspheres are promising controlled release carriers for colon-targeted delivery of FU.

KeyWords: 5-Fluorouracil, pectin, microspheres, Eudragit coating, colon targeting

Full Text

The Full Text of this article is available as a PDF (481.9 KB).

References

  • 1.Riley SA, Turnberg LA. Sulphasalazine and aminosalicylate in the treatment of inflammatory bowl disease. Q J Med. 1990;75:561–562. [PubMed] [Google Scholar]
  • 2.Bartalsky A. Salicylazobenzoic acid in ulcerative colitis. Lancet. 1982;319:960–964. doi: 10.1016/S0140-6736(82)91956-0. [DOI] [PubMed] [Google Scholar]
  • 3.Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. In vitro investigation into the suitability of pH dependent polymer for colonic targeting. Int J Pharm. 1993;95:193–199. doi: 10.1016/0378-5173(93)90406-6. [DOI] [Google Scholar]
  • 4.Marvola M, Nykanen P, Rautio S, Isonen N, Autere AM. Enteric polymer as binder and coating material in multiple unit site-specific drug delivery systems. Eur J Pharm Sci. 1999;7:259–267. doi: 10.1016/S0928-0987(98)00032-3. [DOI] [PubMed] [Google Scholar]
  • 5.Gazzaniga A, Busetti C, Sangali ME, Giordana ME. Time-dependent oral delivery system for colonic targeting system for the colon targeting. STP Pharma Sci. 1995;5:83–88. [Google Scholar]
  • 6.Gazzaniga A, Iamartino P, Maffione G, Sangal ME. Oral delayed release system system for colonic specific delivery. Int J Pharm. 1994;108:77–83. doi: 10.1016/0378-5173(94)90418-9. [DOI] [Google Scholar]
  • 7.Hovgaard L, Brondsted H. Dextran hydrogels for colon-specific drug delivery. J Control Release. 1995;36:159–166. doi: 10.1016/0168-3659(95)00049-E. [DOI] [Google Scholar]
  • 8.Watts PJ, Lllum L. Colonic drug delivery. Drug Dev Ind Pharm. 1997;23:893–913. doi: 10.3109/03639049709148695. [DOI] [Google Scholar]
  • 9.Ashford M, Fell T. Targeting drugs to colon: delivery system for oral administration. J Drug Target. 1994;2:241–258. doi: 10.3109/10611869408996806. [DOI] [PubMed] [Google Scholar]
  • 10.Kudela V. Hydrogels. In: Mark HF, Bikales N, Overberger CG, Menges G, Kroschwitz JI, editors. Encyclopedia of Polymer Science and Engineering. New York, NY: John Wiley & Sons; 1987. pp. 703–807. [Google Scholar]
  • 11.Graham NB, McNeill ME. Hydrogels for controlled drug delivery. Biomaterials. 1984;5:27–36. doi: 10.1016/0142-9612(84)90063-2. [DOI] [PubMed] [Google Scholar]
  • 12.Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech. 2003;4:E31–E31. doi: 10.1208/pt040331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Krusteva S, Lambov N, Velinov G. Pharmaceutical investigation of a bioerodible nystatin system. Pharmazie. 1990;45:195–197. [PubMed] [Google Scholar]
  • 14.Naggar VF, El-Khawas M, Ismail FA, Boraie NA. Pectin, a possible matrix for oral sustained release preparations of water-soluble drugs. STP Pharma Sci. 1992;2:227–234. [Google Scholar]
  • 15.Rubinstein A, Radai R, Ezra M, Pathak S, Rokem JM. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm Res. 1993;10:258–263. doi: 10.1023/A:1018995029167. [DOI] [PubMed] [Google Scholar]
  • 16.Esposito E, Cortesi R, Luca G, Nastruzzi C. Pectin based microspheres: a preformulatory study. Ann N Y Acad Sci. 2001;944:160–179. doi: 10.1111/j.1749-6632.2001.tb03830.x. [DOI] [PubMed] [Google Scholar]
  • 17.Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Design of microen capsulated chitosan microspheres for colonic drug delivery. J Control Release. 1998;52:109–118. doi: 10.1016/S0168-3659(97)00203-4. [DOI] [PubMed] [Google Scholar]
  • 18.Indian Pharmacopoeia.Disintegration and Dissolution. Delhi, India: Controller of Publication-Ministry of Health and Family Welfare; 1996:
  • 19.Rai G, Jain SK, Agrawal S, Pancholi SS, Agrawal GP. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery. Pharmazie. 2005;60:131–134. [PubMed] [Google Scholar]
  • 20.Van den Mooter G, Samyn C, Kinget R. The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery. Pharm Res. 1994;11:1737–1741. doi: 10.1023/A:1018911316021. [DOI] [PubMed] [Google Scholar]
  • 21.Pongpaibul Y, Price JC, Whitworth CW. Preparation and evaluation of controlled release indomethacin microspheres. Drug Dev Ind Pharm. 1984;410:1597–1616. doi: 10.3109/03639048409039070. [DOI] [Google Scholar]
  • 22.Maia JL, Santana MHA, Re MI. The effect of some proceessing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process. Braz J Chem Eng. 2004;21:1–12. doi: 10.1590/S0104-66322004000100002. [DOI] [Google Scholar]
  • 23.Yang Q, Owusu-Ababio G. Biodegradable progesterone microsphere delivery system for osteoporosis therapy. Drug Dev Ind Pharm. 2000;26:61–70. doi: 10.1081/DDC-100100328. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES